13.02.2013
- Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to...
12.02.2013
- For pharmaceutical companies, Africa is changing. Not only is the continent's economic growth grabbing attention in boardrooms but the shifting nature of its disease burden is...
11.02.2013
- Regeneron Pharmaceuticals said its longtime drug-development partner Sanofi aims to boost its stake in the U.S. biotechnology company through open market purchases of its stock...
10.02.2013
- Cedarburg Hauser Pharmaceuticals has announced the addition of controlled substance capabilities at its Denver, CO facility. Both of Cedarburg Hauser's facilities, in Colorado and...
08.02.2013
- Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients...
07.02.2013
- Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...
07.02.2013
- International drug companies are considering bidding for Ache Laboratorios Farmaceuticos, one of Brazil's biggest drugmakers, in a deal valuing it at several billion dollars...
07.02.2013
- French drugmaker Sanofi said earnings could fall this year as it continues to feel the effects of expiring patents, disappointing hopes of a return to growth. The group, which saw...
